The promotion of TCF-1+ TSCM cells is a major goal of prophylactic vaccines that elicit T cell memory and cancer therapeutic vaccines that promote tumor clearance (Held et al., 2019; Lugli et al., 2020; Zhao et al., 2022). This evidence concerns the gene TCF7 and cancer.